Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals-Reference-Cited by-同舟云学术

Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals

Published:2020-01-07 Issue:2 Volume:86 Page:303-317
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Smit Cornelis¹²^ORCID,Wasmann Roeland E.³^ORCID,Goulooze Sebastiaan C.²^ORCID,Wiezer Marinus J.⁴^ORCID,Dongen Eric P.A.⁵,Mouton Johan W.⁶^ORCID,Brüggemann Roger J.M.³^ORCID,Knibbe Catherijne A.J.¹²^ORCID

Affiliation:

1. Department of Clinical PharmacySt. Antonius Hospital Nieuwegein The Netherlands

2. Department of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug ResearchLeiden University Leiden The Netherlands

3. Department of PharmacyRadboud Institute for Health Sciences Radboudumc Nijmegen The Netherlands

4. Department of SurgerySt. Antonius Hospital Nieuwegein The Netherlands

5. Department of AnesthesiologySt. Antonius Hospital Nieuwegein The Netherlands

6. Department of Medical Microbiology and Infectious DiseasesErasmus MC Rotterdam The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14144

Reference40 articles.

1. Trends in Obesity Among Adults in the United States, 2005 to 2014

2. Obesity and infection

3. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters

4. Drug Disposition in Obesity: Toward Evidence-Based Dosing

5. Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing Parametric and Nonparametric Models for Model-Informed Precision Dosing: A Quality Improvement Effort in Vancomycin for Patients With Obesity;Therapeutic Drug Monitoring;2024-05-10

2. Impact of Obesity on Hepatic Drug Clearance: What are the Influential Variables?;The AAPS Journal;2024-05-09

3. Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study;Clinical Pharmacology & Therapeutics;2024-02-26

4. Documentation of the Patient Characteristics Morbid Obesity and Bariatric Surgery in the Hospital Information System and the Influence on the Number of Medication-Related Problems;Annals of Pharmacotherapy;2024-01-24

5. Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action;Clinical Pharmacokinetics;2024-01